Study of Deferasirox for Treatment of Transfusional Iron Overload in Myelodysplastic Patients
Status:
Completed
Trial end date:
2008-03-28
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to examine the safety and efficacy of deferasirox in patients
with Myelodysplastic Syndrome (MDS) and chronic iron overload from blood transfusions.